Acute Myeloid Leukemia Research Today is a free monthly online journal that collates and summarizes the latest research about Acute Myeloid Leukemia, including details on aml, symptoms, treatment, information.

Volume 2 (2005), Issue 1 (January)

1. Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring.
   Cytometry B Clin Cytom, 63(1): 1-9. [Abstract] [Full-text]
2. Targeting NF-kappaB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells.
   Blood, 105(2): 804-11. [Abstract] [Full-text]
3. Immunogenicity of Bcl-2 in patients with cancer.
   Blood, 105(2): 728-34. [Abstract] [Full-text]
4. Novel mechanism of G-CSF refractoriness in patients with severe congenital neutropenia.
   Blood, 105(2): 584-91. [Abstract] [Full-text]
5. A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine.
   Blood, 105(2): 481-8. [Abstract] [Full-text]
6. Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells.
   Nat Med, 11(1): 77-84. [Abstract] [Full-text]
7. Two-dimensional electrophoresis protein profiling as an analytical tool for human acute leukemia classification.
   Electrophoresis, 26(1): 268-79. [Abstract] [Full-text]
8. Clonality analysis of cell lineages in acute myeloid leukemia with inversion 16.
   Cancer Genet Cytogenet, 156(2): 175-8. [Abstract] [Full-text]
9. Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes.
   Cancer Genet Cytogenet, 156(2): 154-7. [Abstract] [Full-text]
10. Mortality in overweight and underweight children with acute myeloid leukemia.
    JAMA, 293(2): 203-11. [Abstract] [Full-text]
11. Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT).
    Bone Marrow Transplant, 35(2): 143-9. [Abstract] [Full-text]
12. Molecularly targeted therapy in acute myeloid leukemia.
    Ann N Y Acad Sci, 1028: 409-22. [Abstract] [Full-text]
13. Myelodysplastic syndromes.
    Ann N Y Acad Sci, 1028: 400-8. [Abstract] [Full-text]
14. Sexual transmission of hepatitis B infection despite the presence of hepatitis B virus immunity in recipients of allogeneic bone marrow transplantation.
    J Clin Virol, 32(2): 173-8. [Abstract] [Full-text]
15. Identification of a SRC-like tyrosine kinase gene, FRK, fused with ETV6 in a patient with acute myelogenous leukemia carrying a t(6;12)(q21;p13) translocation.
    Genes Chromosomes Cancer, 42(3): 269-79. [Abstract] [Full-text]
16. Pattern robustness of diagnostic gene expression signatures in leukemia.
    Genes Chromosomes Cancer, 42(3): 299-307. [Abstract] [Full-text]
17. MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function.
    Mol Cell Biol, 25(3): 988-1002. [Abstract] [Full-text]
18. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
    N Engl J Med, 352(3): 254-66. [Abstract] [Full-text]
19. Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
    J Clin Oncol, 23(3): 482-93. [Abstract] [Full-text]
20. Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias.
    Blood, 105(3): 940-7. [Abstract] [Full-text]
21. A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia.
    Blood, 105(3): 959-67. [Abstract] [Full-text]
22. A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease.
    Blood, 105(3): 986-93. [Abstract] [Full-text]
23. Influence of CD33 expression levels and ITIM-dependent internalization on gemtuzumab ozogamicin-induced cytotoxicity.
    Blood, 105(3): 1295-302. [Abstract] [Full-text]
24. Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases.
    Blood, 105(3): 973-7. [Abstract] [Full-text]
25. Mechanistic role of heat shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cells.
    Blood, 105(3): 1246-55. [Abstract] [Full-text]
26. Angiostatin is a novel anti-inflammatory factor by inhibiting leukocyte recruitment.
    Blood, 105(3): 1036-43. [Abstract] [Full-text]
27. P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway.
    Exp Hematol, 33(1): 62-72. [Abstract] [Full-text]
28. Specific targeting of CD33(+) leukemia cells by a natural killer cell line modified with a chimeric receptor.
    Leuk Res, 29(3): 301-6. [Abstract] [Full-text]
29. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
    Gynecol Oncol, 96(2): 307-13. [Abstract] [Full-text]
30. Myelodysplastic syndrome.
    Annu Rev Med, 56: 1-16. [Abstract] [Full-text]
31. Low toxicity and efficacy of (153)samarium-EDTMP and melphalan as a conditioning regimen for secondary acute myelogenous leukemia.
    Pediatr Transplant, 9(1): 122-6. [Abstract] [Full-text]
32. Amplification or duplication of chromosome band 21q22 with multiple copies of the AML1 gene and mutation of the TP53 gene in therapy-related MDS and AML.
    Leukemia, 19(2): 197-200. [Abstract] [Full-text]
33. CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistance.
    Leukemia, 19(2): 176-82. [Abstract] [Full-text]
34. Congenital leukaemia.
    J Coll Physicians Surg Pak, 15(1): 52-4. [Abstract] [Full-text]
35. AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.
    Proc Natl Acad Sci U S A, 102(4): 1104-9. [Abstract] [Full-text]
36. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
    Bone Marrow Transplant, 35(3): 247-52. [Abstract] [Full-text]
37. Acute myelogenous leukemia suddenly developing just after surgery for advanced gastric cancer: report of a case.
    Surg Today, 35(2): 153-6. [Abstract] [Full-text]
38. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
    Exp Hematol, 33(2): 212-8. [Abstract] [Full-text]
39. Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways.
    Exp Hematol, 33(2): 199-211. [Abstract] [Full-text]
40. The Leukemia-associated ETO homologues are differently expressed during hematopoietic differentiation.
    Exp Hematol, 33(2): 189-98. [Abstract] [Full-text]
41. Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.
    Biol Blood Marrow Transplant, 11(2): 129-35. [Abstract] [Full-text]
42. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
    Biol Blood Marrow Transplant, 11(2): 122-8. [Abstract] [Full-text]
43. Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.
    Biol Blood Marrow Transplant, 11(2): 108-14. [Abstract] [Full-text]
44. Gene selection from microarray data for cancer classification--a machine learning approach.
    Comput Biol Chem, 29(1): 37-46. [Abstract] [Full-text]

© 2004-2008 Acute Myeloid Leukemia Research Today. All Rights Reserved.